Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.08. | Evome Medical Technologies Inc: Evome Medical details low-capex plan for revenue | 1 | Stockwatch | ||
15.08. | Evome Medical Technologies Inc.: Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan | 118 | GlobeNewswire (Europe) | Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical... ► Artikel lesen | |
13.08. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
12.08. | Evome Medical Technologies reports Q2 results | 1 | Seeking Alpha | ||
12.08. | Evome Medical Technologies Inc.: Evome Medical Technologies Reports Second Quarter 2024 Financial Results | 462 | GlobeNewswire (Europe) | Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug.... ► Artikel lesen | |
03.07. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
03.07. | Evome Medical Technologies Inc: Evome hires IR Labs for investor relations | 1 | Stockwatch | ||
03.07. | Evome Medical Technologies Inc.: Evome Medical Technologies Retains irlabs for Investor Relations Services | 1 | GlobeNewswire (USA) | ||
03.07. | Evome Medical Technologies Inc: Evome Medical 504,286 shares for debt | 1 | Stockwatch | ||
17.06. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
14.06. | Evome Medical Technologies Inc: Evome receives conditional OK for shares for services | 1 | Stockwatch | ||
14.06. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Securities Issuances | 1 | GlobeNewswire (USA) | ||
03.06. | Evome Medical Technologies Inc: Evome Medical estimates April, May revenue | 1 | Stockwatch | ||
03.06. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2 | 1 | GlobeNewswire (USA) | ||
01.06. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
30.05. | Evome Medical Technologies Inc: Evome Medical talks Biodex revenue growth | 1 | Stockwatch | ||
30.05. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt | 111 | GlobeNewswire (Europe) | NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue... ► Artikel lesen | |
23.04. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
12.04. | Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled | 109 | GlobeNewswire (Europe) | NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's... ► Artikel lesen | |
01.04. | Evome Medical Technologies Inc.: Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023 | 125 | GlobeNewswire (Europe) | NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023.... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,350 | -0,95 % | Fresenius SE Aktie: Kursrückgang trotz positiver Analystenprogn | Die Fresenius SE-Aktie verzeichnete am Donnerstag einen leichten Rückgang im XETRA-Handel. Gegen Mittag notierte der Anteilsschein 0,6 Prozent im Minus bei 33,46 Euro. Trotz des aktuellen Kursrückgangs... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,82 | -0,12 % | Siemens Healthineers Aktie: Positive Entwicklung trotz Marktvolatilität | Die Siemens Healthineers Aktie zeigt sich in einem volatilen Marktumfeld robust. Am jüngsten Handelstag verzeichnete das Wertpapier im XETRA-Handel einen Anstieg um 0,9 Prozent auf 52,40 EUR. Damit... ► Artikel lesen | |
GERRESHEIMER | 85,90 | +3,81 % | Aroundtown, Aurubis, Gerresheimer, Lanxess, Rheinmetall, SMA Solar u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,130 | +0,35 % | Neue 9,00% Aktienanleihe mit Barriere auf Fresenius Medical Care in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC5UPA5/ WKN VC5UPA) mit Barriere auf die Aktie von Fresenius... ► Artikel lesen | |
CARL ZEISS MEDITEC | 61,80 | +0,90 % | Carl Zeiss Meditec Aktie: Kursanstieg trotz volatiler Marktlage | Die Aktie von Carl Zeiss Meditec verzeichnete am heutigen Handelstag einen erfreulichen Aufschwung. Im XETRA-Handel kletterte der Kurs um 1,0 Prozent auf 66,40 Euro. Trotz der jüngsten Marktschwankungen... ► Artikel lesen | |
CASTLE BIOSCIENCES | 33,060 | -2,10 % | Castle Biosciences (NASDAQ:CSTL) Sees Unusually-High Trading Volume Following Analyst Upgrade | ||
PROGYNY | 16,670 | 0,00 % | Progyny, Inc. Announces Second Quarter 2024 Results | Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:... ► Artikel lesen | |
ADAPTHEALTH | 10,830 | -0,28 % | AdaptHealth erweitert Vorstand mit erfahrener Expertin für Gesundheitstechnologie | ||
RXSIGHT | 49,970 | -1,36 % | RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds | ||
GENEDX | 56,01 | -7,85 % | The Analyst Verdict: GeneDx Holdings In The Eyes Of 6 Experts | ||
TEMPUS AI | 48,000 | 0,00 % | Cathie Woods ARK ETF konzentriert sich auf Tempus AI und AMD-Aktien | ||
PROCEPT BIOROBOTICS | 69,12 | -4,61 % | PROCEPT BioRobotics Co. (NASDAQ:PRCT) CFO Kevin Waters Sells 25,000 Shares | ||
ECKERT & ZIEGLER | 42,700 | +1,76 % | EQS-Adhoc: Eckert & Ziegler SE: Eckert & Ziegler mit anhaltendem Umsatz- und Gewinnwachstum in den ersten 9 Monaten gegenüber Vorjahr | EQS-Ad-hoc: Eckert & Ziegler SE / Schlagwort(e): 9-Monatszahlen/Vorläufiges Ergebnis
Eckert & Ziegler mit anhaltendem Umsatz- und Gewinnwachstum in den ersten 9 Monaten gegenüber Vorjahr
15.10.2024... ► Artikel lesen | |
CERIBELL | 26,490 | 0,00 % | CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | SUNNYVALE, Calif., Oct. 15, 2024 /PRNewswire/ -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of... ► Artikel lesen | |
NANO-X IMAGING | 6,010 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen |